Primaries non-migraine headaches treatment: a review

被引:0
|
作者
Fabio Frediani
Gennaro Bussone
机构
[1] ASST Santi Paolo & Carlo,Headache Center, Neurology and Stroke Unit S. Carlo Hospital
[2] National Neurological Institute Carlo Besta,undefined
来源
Neurological Sciences | 2020年 / 41卷
关键词
Tension-type headache; TACs; Cluster headache; Headache therapy;
D O I
暂无
中图分类号
学科分类号
摘要
In the “headache world,” great attention has always been paid to migraine patients, especially for the research and development of new therapies. For the other forms of primary headaches, especially those of Chapters 2 and 3 of the classification, there are however therapies that, even if not specific, can give significant results. Tension-type headache recognizes in NSAIDs the most effective drugs to treat acute attack, while prevention is based on the use of tricyclic antidepressants and muscle relaxants. For TACs, the discussion is more complex: first of all, there are two forms of primary headache that respond absolutely to indomethacin. For these, the main problem is how to manage the possible side effects arising from prolonged treatments and possibly what to use as an alternative. For cluster headaches and short-lasting unilateral neuralgiform headache attacks, we have drugs with good efficacy as regards medical therapy, such as verapamil or lamotrigine, but in recent years, neuromodulation techniques, both surgical and non-invasive, have also been affirming themselves, which represent a more possibility for forms of headache that are often very disabling and resistant to common analgesics.
引用
收藏
页码:385 / 394
页数:9
相关论文
共 50 条
  • [41] Surgical treatment of migraine headaches
    Gfrerer, Lisa
    Guyuron, Bahman
    ACTA NEUROLOGICA BELGICA, 2017, 117 (01) : 27 - 32
  • [42] Acute Treatment of Migraine Headaches
    Taylor, Frederick R.
    SEMINARS IN NEUROLOGY, 2010, 30 (02) : 145 - 153
  • [43] Pharmacokinetics of Oral and Transdermal Sumatriptan during Acute Migraine and Non-Migraine Periods: Incidence of the Migraine Effect
    Wilks, K.
    Pierce, M.
    O'Neill, C.
    Angelov, A. S.
    Du, W.
    Safirstein, B.
    HEADACHE, 2010, 50 : S26 - S27
  • [44] Self-perceived attention deficit and hyperactivity symptom levels and risk of non-migraine and migraine headaches among university students: A cross-sectional study
    Carpenet, Claire
    Guichard, Elie
    Tzourio, Christophe
    Kurth, Tobias
    CEPHALALGIA, 2019, 39 (06) : 711 - 721
  • [45] A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches
    Jacquelin Peck
    Ivan Urits
    Justin Zeien
    Shelby Hoebee
    Mohammad Mousa
    Hamed Alattar
    Alan D. Kaye
    Omar Viswanath
    Current Pain and Headache Reports, 2020, 24
  • [46] Migraine headaches and preeclampsia: An epidemiologic review
    Adeney, KL
    Williams, MA
    HEADACHE, 2006, 46 (05): : 794 - 803
  • [47] A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches
    Peck, Jacquelin
    Urits, Ivan
    Zeien, Justin
    Hoebee, Shelby
    Mousa, Mohammad
    Alattar, Hamed
    Kaye, Alan D.
    Viswanath, Omar
    CURRENT PAIN AND HEADACHE REPORTS, 2020, 24 (05)
  • [48] Molecular genetics of migraine headaches: a review
    Montagna, P
    CEPHALALGIA, 2000, 20 (01) : 3 - 14
  • [49] Topical Prostaglandins in the Treatment of Migraine Headaches
    Wand, M.
    Hall, L. B.
    Venkatesh, B.
    Teng, C. C.
    Shingleton, B.
    Hutchinson, B. Thomas
    Bratzler, R.
    HEADACHE, 2018, 58 : 99 - 100
  • [50] RimabotulinumtoxinB for preventive treatment of migraine headaches
    Grogan, P. M.
    Alvarez, M. V.
    TOXICON, 2013, 68 : 74 - 75